Stay updated with breaking news from Mark Enyedy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ImmunoGen Inc shares rocketed higher Friday after the company’s first quarter sales impressed investors. The Massachusetts-based company posted revenue of...
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Isabel Kalofonos has been appointed Senior Vice President and Chief... | June 18, 2023
ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Isabel Kalofonos has been appointed Senior Vice President and Chief Commercial Officer. "We are excited to welcome Isabel to ImmunoGen's Executive Committee to lead ...
ImmunoGen to Receive $75 Million Upon Execution of the Agreement; Eligible to Receive up to an Additional $100 Million in Near-Term Proceeds ... | April 6, 2023
Operator: Good morning, and welcome to ImmunoGen's Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. Today's conference is being recorded.